Market Place
Sourcing Support
Mallinckrodt Presents Data on TERLIVAZ® for Hepatorenal Syndrome
18 Nov 2024 //
PR NEWSWIRE
Mallinckrodt to Present TERLIVAZ® Data at AASLD Annual Meeting
30 Oct 2024 //
PR NEWSWIRE
Mallinckrodt Presents Terlivaz® Data For Hepatorenal Syndrome
29 Oct 2024 //
PR NEWSWIRE
BioVie Receives Notice Of Allowance For Japan Patent Application
15 Oct 2024 //
GLOBENEWSWIRE
Mallinckrodt presents data on Terlivaz for inj with hepatorenal syndrome at 2024
20 May 2024 //
PHARMABIZ
Mallinckrodt Presents TERLIVAZ HRS Data At DDW 2024
18 May 2024 //
PR NEWSWIRE
Enforcement Report - Week of February 28, 2024
28 Feb 2024 //
FDA
Mallinckrodt Presents New Data on TERLIVAZ for Injection at SCCM
22 Jan 2024 //
PR NEWSWIRE
Mallinckrodt Announces Journal Publication of Economic Evidence for TERLIVAZ
21 Dec 2023 //
PR NEWSWIRE
Mallinckrodt to Present Breadth of Data on TERLIVAZ (terlipressin) for Injection
08 Nov 2023 //
PR NEWSWIRE
Mallinckrodt to Present Data on TERLIVAZ for Injection in Adult Patients
01 Nov 2023 //
PR NEWSWIRE
Mallinckrodt to Present Data on TERLIVAZ for Injection in Patients with HRS
22 Oct 2023 //
PR NEWSWIRE
Mallinckrodt to Present Data on TERLIVAZ
15 Jun 2023 //
PR NEWSWIRE
Mallinckrodt Presents Clinical Data for TERLIVAZ® (terlipressin) for Injection
01 Jun 2023 //
PR NEWSWIRE
Mallinckrodt Presents Clinical Data for TERLIVAZ® (terlipressin) for Injection
08 May 2023 //
PR NEWSWIRE
2022 drug approvals: Biopharma delivered 37 new drugs
03 Jan 2023 //
FIERCE PHARMA
Mallinckrodt to Present Data on TERLIVAZ for Injection in Patients with HRS
03 Nov 2022 //
PRNEWSWIRE
Mallinckrodt to Present Data on TERLIVAZ for Injection in Patients with HRS
24 Oct 2022 //
PRNEWSWIRE
EMA makes new recommendations for Imbruvica
01 Oct 2022 //
ENPTS
FDA blesses Mallinckrodt`s Terlivaz for kidney failure drug
16 Sep 2022 //
FIERCEPHARMA
Mallinckrodt Receives U.S. FDA Approval for Terlivaz for injection
14 Sep 2022 //
PRNEWSWIRE
Mallinckrodt Announces Data at Kidney Week 2020 Reimagined that Showed A
29 Oct 2020 //
PRNEWSWIRE
Terlipressin Squeaks by FDA Review for Hepatorenal Syndrome 1
16 Jul 2020 //
MEDSAPE
US committee backs terlipressin approval for HRS-1
15 Jul 2020 //
PHARMATIMLES
FDA staff question endpoint for Mallinckrodt’s terlipressin
14 Jul 2020 //
FIERCE BIOTECH
Mallinckrodt Confirms that U.S. (FDA) Will Convene to Review Terlipressin
07 Jul 2020 //
PRNEWSWIRE
Real-World Data of Terlipressin in Hospitalized Patients in U.K
10 Jun 2020 //
PRNEWSWIRE
Mallinckrodt Announces U.S. FDA Filing Acceptance of NDA for Terlipressin
22 Apr 2020 //
PR NEWSWIRE
Mallinckrodt Completes Rolling Submission of New Drug Application to the FDA
17 Mar 2020 //
PR NEWSWIRE
Development of coronavirus treatment advancing in Japan with existing meds
17 Mar 2020 //
MAINICHI
Mallinckrodt Presents +ve Ph3 Results from its CONFIRM Study of Terlipressin
12 Nov 2019 //
PR NEWSWIRE
Mallinckrodt Presents +ve Phase 3 Results from its CONFIRM Study of Terlipressin
11 Nov 2019 //
PR NEWSWIRE
Mallinckrodt to Present Results from its Pivotal Ph3 CONFIRM Study Terlipressin
21 Oct 2019 //
PR NRWSWIRE
Government to reconsider NHS Health Checks
16 Aug 2019 //
PHARMA TIMES
Mallinckrodt’s terlipressin shows positive profile in CONFIRM study
16 Aug 2019 //
CLINICALTRIAL SARENA
Ailing Mallinckrodt`s drug for rare, life-threatening renal condition
15 Aug 2019 //
ENDPTS
Sun-Ranbaxy Merger: CCI Approves Divestment of Seven Brands to Emcure
24 Mar 2015 //
BUSINESS STANDARD
